Adenosine as an antiarrhythmic agent (Q41531534)

2 October 2017

1 reference

title

Adenosine as an antiarrhythmic agent (English)

1 reference

2 October 2017

Francis E. Marchlinski

series ordinal

2

1 reference

2 October 2017

1

S L Wilbur

1 reference

PubMed ID

9223361

2 October 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

American Journal of Cardiology

2 October 2017

1 reference

2 October 2017

79

1 reference

2 October 2017

12A

1 reference

2 October 2017

30-37

1 reference

The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

The cardiac effects of adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Cardiac electrophysiology of adenosine. Basic and clinical concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Selective effects of adenosine receptor agonists upon coronary resistance and heart rate in isolated working rabbit hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine 3',5'-monophosphate formation and glycogen phosphorylase activity in rat heart muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Inhibition of cardiac sympathetic neurotransmission by adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Functional role of cholinoceptors and purinoceptors in human isolated atrial and ventricular heart muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Adenosine increases sympathetic nerve traffic in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Mechanism-specific effects of adenosine on atrial tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Failure of adenosine to terminate focal atrial tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Termination of focal atrial tachycardia by adenosine triphosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Effects of adenosine and adenine nucleotides on the atrioventricular node of isolated guinea pig hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Supraventricular Tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Effect of adenosine or adenosine triphosphate on antidromic tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Use of adenosine-sensitive nondecremental accessory pathways in assessing the results of radiofrequency catheter ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Effects of intravenous adenosine on antegrade refractoriness of accessory atrioventricular connections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Dipyridamole inhibition of adenosine metabolism in human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Measurement of adenosine, inosine, and hypoxanthine in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Turnover of adenosine in plasma of human and dog blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Safety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Management of cardiac arrhythmias during pregnancy. Current concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Rapid and safe termination of supraventricular tachycardia in children by adenosine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Use of adenosine in the management of perioperative arrhythmias in the pediatric cardiac intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Usefulness of adenosine for arrhythmias in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Cardiovascular collapse after verapamil in supraventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Effect of infused adenosine on cardiac output and systemic resistance in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Adenosine stimulates respiration in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Role of adenosine in pathogenesis of anginal pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Adenosine-provoked angina pectoris-like pain--time characteristics, influence of autonomic blockade and naloxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Untoward reaction to adenosine therapy for supraventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Life-threatening alterations in heart rate after the use of adenosine in atrial flutter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Spatial and temporal inhomogeneity of adenosine's effect on atrial refractoriness in humans: using atrial fibrillation to probe atrial refractoriness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Acceleration of ventricular response to atrial flutter after intravenous adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Proarrhythmic effect of adenosine in a patient with atrial flutter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Adenosine-induced torsades de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

Ventricular fibrillation following adenosine administration. A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900261-0

10.1016/S0002-9149(97)00261-0

7 January 2021

Identifiers

DOI

1 reference

2 October 2017

1 reference

PubMed ID

9223361